Tocopherol supplementation reduces NO production and pulmonary inflammatory response to bleomycin

Nitric Oxide - Biology and Chemistry

Volumn 34, Issue , 2013, Pages 27-36

  Shi, Jin Dong ^b   Golden, Thea ^a   Guo, Chang Jiang ^a   Tu, Shui Ping ^a   Scott, Pamela ^a   Lee, Mao Jung ^a   Yang, Chung S ^a   Gow, Andrew J ^a  

^a RUTGERS UNIVERSITY   (United States)

^b FUDAN UNIVERSITY   (China)

Author keywords

Lung mechanics; Macrophage activation; Macrophage phenotype; Reactive oxygen and nitrogen species

Indexed keywords

BLEOMYCIN; CYTOKINE; NITRIC OXIDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TOCOPHEROL;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG DELIVERY SYSTEM; DRUG RESPONSE; ENZYME INDUCTION; HISTOPATHOLOGY; LUNG MECHANICS; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; VITAMIN SUPPLEMENTATION;

ANIMALIA; MUS;

LUNG MECHANICS; MACROPHAGE ACTIVATION; MACROPHAGE PHENOTYPE; REACTIVE OXYGEN AND NITROGEN SPECIES;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; CYCLOOXYGENASE 2; LUNG; LUNG INJURY; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PNEUMONIA; REACTIVE OXYGEN SPECIES; RESPIRATORY FUNCTION TESTS; TOCOPHEROLS;

EID: 84885186069     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2013.04.006     Document Type: Article

References (26)

1. J. Hay, S. Shahzeidi, G. Laurent, Mechanisms of bleomycin-induced lung damage, Arch. Toxicol. 65 (1991) 81-94.
2. M.A. Santos-Silva, K.M. Pires, E.T. Trajano, V. Martins, R.T. Nesi, C.F. Benjamin, M.S. Caetano, C. Sternberg, M.N. Machado, W.A. Zin, S.S. Valenca, L.C. Porto, Redox imbalance and pulmonary function in bleomycin-induced fibrosis in C57BL/6, DBA/2, and BALB/c mice, Toxicol. Pathol. 40 (2012) 731-741.
3. S.M. Togeiro, G. Carneiro, F.F. Filho, M.T. Zanella, R. Santos-Silva, J.A. Taddei, L.R. Bittencourt, S. Tufik, Consequences of obstructive sleep apnea on metabolic profile: a population-based survey, Obesity (Silver Spring) (2012).
4. K. Tanaka, T. Ishihara, A. Azuma, S. Kudoh, M. Ebina, T. Nukiwa, Y. Sugiyama, Y. Tasaka, T. Namba, K. Sato, Y. Mizushima, T. Mizushima, Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis, Am. J. Physiol. Lung Cell. Mol. Physiol. 298 (2010) L348.
5. K. Tanaka, Y. Tanaka, T. Namba, A. Azuma, T. Mizushima, Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice, Biochem. Pharmacol. 80 (2010) 920-931.
6. H. Mert, I. Yoruk, A. Ertekin, S. Dede, Y. Deger, F. Yur, N. Mert, Vitamin levels in lung tissue of rats with bleomycin induced pulmonary fibrosis, J. Nutr. Sci. Vitaminol. (Tokyo) 55 (2009) 186-190.
7. Z.E. Suntres, P.N. Shek, Protective effect of liposomal alpha-tocopherol against bleomycin-induced lung injury, Biomed. Environ. Sci. 10 (1997) 47-59. (Pubitemid 127468671)
8. S. Campbell, W. Stone, S. Whaley, K. Krishnan, Development of gamma (gamma)-tocopherol as a colorectal cancer chemopreventive agent, Crit. Rev. Oncol. Hematol. 47 (2003) 249-259. (Pubitemid 37072117)
9. J. Ju, S.C. Picinich, Z. Yang, Y. Zhao, N. Suh, A.N. Kong, C.S. Yang, Cancerpreventive activities of tocopherols and tocotrienols, Carcinogenesis 31 (2010) 533-542.
10. T. Genovese, S. Cuzzocrea, R. Di Paola, M. Failla, E. Mazzon, M.A. Sortino, G. Frasca, E. Gili, N. Crimi, A.P. Caputi, C. Vancheri, Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury, Respir. Res. 6 (2005) 58.
11. A.S. Kristof, P. Goldberg, V. Laubach, S.N. Hussain, Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury, Am. J. Respir. Crit. Care Med. 158 (1998) 1883-1889. (Pubitemid 29008829)
12. E.N. Atochina-Vasserman, M.F. Beers, H. Kadire, Y. Tomer, A. Inch, P. Scott, C.J. Guo, A.J. Gow, Selective inhibition of inducible NO synthase activity in vivo reverses inflammatory abnormalities in surfactant protein D-deficient mice, J. Immunol. 179 (2007) 8090-8097.
13. P.G. Reeves, F.H. Nielsen, G.C. Fahey Jr., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet, J. Nutr. 123 (1993) 1939-1951. (Pubitemid 23342492)
14. F. Guan, G. Li, A.B. Liu, M.J. Lee, Z. Yang, Y.K. Chen, Y. Lin, W. Shih, C.S. Yang, Delta- and gamma-tocopherols, but not alpha-tocopherol, inhibit colon carcinogenesis in azoxymethane-treated F344 rats, Cancer Prev. Res. (Phila) 5 (2012) 644-654.
15. D.G. Rudmann, A.M. Preston, M.W. Moore, J.M. Beck, Susceptibility to Pneumocystis carinii in mice is dependent on simultaneous deletion of IFNgamma and type 1 and 2 TNF receptor genes, J. Immunol. 161 (1998) 360-366. (Pubitemid 28285543)
16. F.M. Menzies, F.L. Henriquez, J. Alexander, C.W. Roberts, Sequential expression of macrophage anti-microbial/inflammatory and wound healing markers following innate, alternative and classical activation, Clin. Exp. Immunol. 160 (2010) 369-379.
17. A. Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi, M. Locati, The chemokine system in diverse forms of macrophage activation and polarization, Trends Immunol. 25 (2004) 677-686. (Pubitemid 39457982)
18. S. Gordon, P.R. Taylor, Monocyte and macrophage heterogeneity, Nat. Rev. Immunol. 5 (2005) 953-964. (Pubitemid 41746764)
19. S.M. Hecht, Bleomycin: new perspectives on the mechanism of action, J. Nat. Prod. 63 (2000) 158-168. (Pubitemid 30078794)
20. M. McVean, D.C. Liebler, Prevention of DNA photodamage by vitamin E compounds and sunscreens: roles of ultraviolet absorbance and cellular uptake, Mol. Carcinog. 24 (1999) 169-176. (Pubitemid 29169857)
21. S.I. Hung, A.C. Chang, I. Kato, N.C. Chang, Transient expression of Ym1, a heparin-binding lectin, during developmental hematopoiesis and inflammation, J. Leukoc. Biol. 72 (2002) 72-82.
22. G. Raes, P. De Baetselier, W. Noel, A. Beschin, F. Brombacher, G. Hassanzadeh Gh, Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages, J. Leukoc. Biol. 71 (2002) 597-602.
23. Z. Hantos, B. Daroczy, T. Csendes, B. Suki, S. Nagy, Modeling of low-frequency pulmonary impedance in dogs, J. Appl. Physiol. 68 (1990) 849-860. (Pubitemid 20136405)
24. D.W. Kaczka, D.N. Hager, M.L. Hawley, B.A. Simon, Quantifying mechanical heterogeneity in canine acute lung injury: impact of mean airway pressure, Anesthesiology 103 (2005) 306-317. (Pubitemid 41076728)
25. S. Ito, E.P. Ingenito, S.P. Arold, H. Parameswaran, N.T. Tgavalekos, K.R. Lutchen, B. Suki, Tissue heterogeneity in the mouse lung: effects of elastase treatment, J. Appl. Physiol. 97 (2004) 204-212. (Pubitemid 38802521)
26. J.H.T. Bates, Lung Mechanics: An Inverse Modeling Approach, Cambridge University Press, United Kingdom, 2009.